We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
-4.52%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
10 Year Est. Return
AUM
$99.7M
AUM Growth
-$7.72M
Cap. Flow
-$1.97M
Cap. Flow %
-1.98%
Top 10 Hldgs %
20.61%
Holding
65
New
2
Increased
1
Reduced
60
Closed
2

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$1.85M
2
KR icon
Kroger
KR
+$1.74M
3
MDT icon
Medtronic
MDT
+$31.9K

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$1.33M
2
GPC icon
Genuine Parts
GPC
+$288K
3
WBD icon
Warner Bros
WBD
+$149K
4
AMGN icon
Amgen
AMGN
+$149K
5
NXST icon
Nexstar Media Group
NXST
+$86.9K

Sector Composition

Rank Sector Weight
1 Financials 20.76%
2 Healthcare 18.69%
3 Industrials 10.11%
4 Technology 10.09%
5 Energy 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEN icon
51
Franklin Resources
BEN
$16.9B
$1.28M 1.29%
59,565
-2,146
-3% -$55.2K
TFC icon
52
Truist Financial
TFC
$63.9B
$1.26M 1.27%
29,043
-1,043
-3% -$50.2K
MDT icon
53
Medtronic
MDT
$116B
$1.25M 1.26%
15,517
+355
+2% +$31.9K
JPM icon
54
JPMorgan Chase
JPM
$962B
$1.25M 1.26%
11,984
-435
-4% -$49.9K
EMN icon
55
Eastman Chemical
EMN
$8.55B
$1.24M 1.24%
17,402
-625
-3% -$56.2K
STOR
56
DELISTED
STORE Capital Corporation
STOR
$1.24M 1.24%
39,459
-1,424
-3% -$40.5K
WBA
57
DELISTED
Walgreens Boots Alliance
WBA
$1.21M 1.22%
38,616
-1,774
-4% -$65.7K
BBY icon
58
Best Buy
BBY
$17.6B
$1.2M 1.21%
19,014
-893
-4% -$66.1K
MPC icon
59
Marathon Petroleum
MPC
$94.5B
$1.08M 1.08%
10,837
-387
-3% -$36.2K
OHI icon
60
Omega Healthcare
OHI
$13.8B
$1.07M 1.07%
36,333
-1,317
-3% -$41.3K
TROW icon
61
T. Rowe Price
TROW
$24.3B
$1.02M 1.02%
9,704
-346
-3% -$41.3K
T icon
62
AT&T
T
$168B
$714K 0.72%
46,518
-2,228
-5% -$40.5K
CAH icon
63
Cardinal Health
CAH
$56.3B
$246K 0.25%
3,686
-503
-12% -$31.9K
MMM icon
64
3M
MMM
$94.4B
-12,267
Closed -$1.33M
WBD icon
65
Warner Bros
WBD
$67.9B
-11,132
Closed -$149K

Similar funds

Weaver C. Barksdale & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Weaver C. Barksdale & Associates held 65 positions worth $99.7M, down 7.2% from $107M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Weaver C. Barksdale & Associates's Q3 2022 filing shows 2 new, 1 increased, 60 reduced and 2 closed positions. Its largest new stake was Gilead Sciences: 29,289 shares worth $1.81M. The largest sale was 3M, an estimated $1.33M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

  • Weaver C. Barksdale & Associates's largest Q3 2022 buy was Gilead Sciences: 29,289 shares worth $1.81M.
  • Weaver C. Barksdale & Associates added most to Medtronic in Q3 2022, an estimated $31.9K increase.
  • Weaver C. Barksdale & Associates's biggest Q3 2022 reduction was Genuine Parts, cutting an estimated $288K.
  • Weaver C. Barksdale & Associates fully exited 3M in Q3 2022, selling an estimated $1.33M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 21% of its $99.7M portfolio in Q3 2022.
  • Weaver C. Barksdale & Associates opened 2 new positions and closed 2 in Q3 2022.
  • Weaver C. Barksdale & Associates's portfolio value fell 7.2% quarter-over-quarter to $99.7M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q3 2022, filed 14 Nov 2022.